425
Participants
Start Date
June 26, 2014
Primary Completion Date
January 25, 2018
Study Completion Date
January 25, 2018
AT-III (Human)
AT-III (Human) is an antithrombin concentrate prepared from pooled human plasma. AT-III (Human) is provided as a freeze-dried preparation for intravenous use. The AT-III (Human) preparation is reconstituted in 10 or 20 mL of sterile water for injection prior to intravenous administration.
Placebo
0.9% Sodium Chloride for Injection, United States Pharmacopeia
North Shore University Hospital, New Hyde Park
UPMC Presbyterian Hospital, Pittsburgh
University of Pennsylvania, Philadelphia
Cardiothoracic Surgical Associates, Richmond
Virginia Commonwealth University Medical Center, Richmond
Duke University Medical Center, Durham
Emory University Hospital, Atlanta
Georgia Regents University, Augusta
University of Florida College of Medicine, Gainesville
Jackson Memorial Hospital at University of Miami, Miami
St. Thomas Health, Nashville
Baptist Memorial Hospital Memphis, Memphis
Kentucky Clinic, Lexington
The Ohio State University Wexner Medical Center, Columbus
ProMedica Toledo Hospital, Toledo
University of Toledo Medical Center, Toledo
University Hospitals Case Medical Center, Cleveland
Summa Health Hospital, Akron
The Lindner Center for Research & Education - The Christ Hospital, Cincinnati
St. Vincent Heart Center of IN, LLC, Indianapolis
Indiana Ohio Heart, Fort Wayne
William Beaumont Hospital, Royal Oak
Sparrow Clinical Research Institute, Lansing
Sanford Health Fargo, Fargo
Memorial Medical Center, Springfield
Missouri Baptist Medical Center, St Louis
Saint Luke's Hospital, Kansas City
University of Nebraska Medical Center, Omaha
CHI Health Nebraska Heart Medical Office, Lincoln
Tulane University Medical, New Orleans
Texas Heart, Houston
Memorial Hermann Memorial City Medical Center, Bellaire
University of Colorado, Aurora
UC Irvine, Orange
VA Medical Center - San Francisco, San Francisco
Stanford University Hospital and Clinics, Stanford
Oregon Health & Science University, Portland
Yale University School of Medicine, New Haven
Maine Medical Center, Portland
Brigham & Women's Hospital, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Lead Sponsor
Collaborators (2)
Covance
INDUSTRY
Clinipace Worldwide
INDUSTRY
Grifols Therapeutics LLC
INDUSTRY